U.S. Logistics Stock News

Niagen Bioscience (NAGE) has been drawing attention after its recent rebranding from ChromaDex Corporation, shifting investor focus toward its healthy aging product portfolio and proprietary NIAGEN ingredient as the stock reacts to this corporate transition. See our latest analysis for Niagen Bioscience. Recent trading has been weaker for Niagen Bioscience, with the share price at about US$3.30 after declining around 15% over the past month and about 47% year to date. The 3 year total...

The Supreme Court’s decision to uphold birthright citizenship removes a major source of uncertainty for millions of families and the employers that rely on them. For investors, clearer immigration rules can mean steadier labor supply and more predictable consumer demand, which can matter as much as any earnings report. This article looks at three stocks exposed to this ruling through their dependence on immigrant workers or diverse customer bases. Each one could see business conditions shaped...

Easterly Government Properties recently closed a new five-year US$200,000,000 senior unsecured term loan facility, which includes an accordion feature allowing total commitments to rise to as much as US$250,000,000 and matures in June 2031. The company plans to use the proceeds to repay borrowings under its US$400,000,000 revolving credit facility and for general corporate purposes, effectively reshaping its mix of revolving and term debt while locking in pricing tied to its current leverage...

The obesity and metabolic drug space is suddenly in the spotlight, and not just because of headlines around GLP-1 treatments. A Supreme Court ruling on executive power, Medicare’s move to start covering obesity drugs, and a record close for the Dow are all feeding into a new conversation about where risk and opportunity may sit in this corner of healthcare. This article looks at 3 stocks from our Healthcare Sector, Obesity and Metabolic Drug Manufacturers screener that appear particularly...

Index additions put Custom Truck One Source in focus Custom Truck One Source (CTOS) has attracted fresh attention after being added to several Russell growth indices, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, and Small Cap Comp Growth benchmarks. See our latest analysis for Custom Truck One Source. Custom Truck One Source has already seen strong share price momentum, with a 30 day share price return of 24.7%, a 90 day return of 81.9% and a year to date gain of...

AEVEX (AVEX) stock is back in focus after the company reported a new US$50 million contract from the United States Air Force to expand unmanned mission support and long range precision strike capabilities. See our latest analysis for AEVEX. Those contracts and AEVEX’s recent additions to several Russell indices have put the stock back in the spotlight. Yet the 30 day share price return is down 53.37% and the year to date share price return is down 33.38%, even after a 4.30% one day and 2.63%...

The sudden decision for Medicare to temporarily cover obesity drugs like Wegovy and Zepbound has put a spotlight on pharmaceutical companies working in obesity and metabolic disorders. With millions of eligible seniors now facing a defined $50 monthly copay and a clear end date for coverage in 2027, the stakes are high for both investors and patients. This article looks at how that catalyst connects to three stocks exposed to the news, all drawn from a focused screener of larger healthcare...

AI heavyweights in the Magnificent 7 have just seen about US$2.3t in value wiped away as investors question massive, often debt-fueled, infrastructure spending and wait for second quarter earnings to show clearer payoffs. At the same time, semiconductor stocks linked to that same AI buildout are seeing stronger interest, helped by chip supply bottlenecks, higher memory prices and solid reports from companies such as Micron. This article looks at 3 stocks from a Semiconductor Stocks screener...

Regulators are turning up the heat on technology, data, and digital infrastructure, and that shift is increasingly reflected in how investors think about risk and opportunity. When rules tighten around cybersecurity, compliance, and critical systems, some stocks can find themselves better placed to win contracts, build trust, or secure longer term revenue visibility, while others may face heavier costs or business friction. This article looks at 3 stocks from our Regulatory Beneficiaries in...

NWPX Infrastructure (NWPX) was recently added to several Russell growth indices, a shift that can influence how index funds and institutional investors approach the stock and its role in diversified portfolios. See our latest analysis for NWPX Infrastructure. Against this backdrop, NWPX Infrastructure has shown strong momentum, with a 30-day share price return of 26.63%, a 90-day share price return of 91.84%, and a 1-year total shareholder return of 264.23%. This suggests investors are...

We can readily understand why investors are attracted to unprofitable companies. Indeed, Zura Bio ( NASDAQ:ZURA ) stock...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

What Mirion’s New Index Inclusions Mean For Investors Mirion Technologies (MIR) has been added to several Russell indices, including multiple value and defensive benchmarks. This type of change can affect how index-tracking funds and institutional investors approach the stock. For you as a shareholder or potential buyer, these index additions matter because they can influence trading volumes, ownership mix, and how the market views Mirion within the small cap and value segments. See our...

Pursuit Attractions and Hospitality (NYSE:PRSU) has been added to multiple Russell 2000 indexes. The additions include the Growth Defensive, Value Defensive, and Defensive variants of the Russell 2000. Index inclusion can attract attention from funds and investors that track or reference these benchmarks. Pursuit Attractions and Hospitality operates in the attractions and hospitality space, an area that often sits at the crossroads of tourism, consumer spending, and real estate. Being...

Adobe is rolling out AI driven upgrades across Firefly, Creative Cloud, GenStudio, and CX Enterprise, with new agentic workflows connecting creative tools and marketing systems. A fresh partnership with LiveRamp is aimed at tying Adobe's creative and experience platforms to commerce media data and activation. Enterprise collaborations with firms such as Accenture, Microsoft, and WPP are expanding the reach of Adobe's AI centric content and marketing stack. NasdaqGS:ADBE has also been added...

Insiders who bought US$347.5k worth of Jasper Therapeutics, Inc.'s ( NASDAQ:JSPR ) stock at an average buy price of...

If you are wondering whether W. R. Berkley stock offers good value at its current price, the key is understanding how that price lines up against a few different valuation yardsticks. The stock recently closed at US$71.01, with returns of 5.8% over the past week and 11.8% over the past month, while the 1 year return is a decline of 0.7% and the 3 year and 5 year returns sit at 93.2% and 137.0% respectively. Recent news coverage around W. R. Berkley has focused on the company's position in...

Over the last 7 days, the United States market has remained flat, although it has seen a significant rise of 20% over the past year, with earnings expected to grow by 19% annually in the coming years. In this environment, identifying small-cap stocks that are potentially undervalued and have notable insider actions can offer intriguing opportunities for investors seeking to capitalize on future growth.

Orchestra BioMed Holdings, Inc. ( NASDAQ:OBIO ) insiders who bought shares over the past year were rewarded handsomely...

Over the last 7 days, the United States market has remained flat, yet over the past 12 months, it has seen a notable rise of 20%, with earnings forecasted to grow by 19% annually. In this landscape, identifying high growth tech stocks involves focusing on companies that demonstrate strong innovation and scalability potential to align with these promising growth forecasts.

Over the last 7 days, the United States market has remained flat, yet it has seen a 20% increase over the past year with earnings projected to grow by 19% annually in the coming years. In this context, identifying stocks that are potentially undervalued can be an advantageous strategy for investors looking to capitalize on future growth opportunities while benefiting from current market conditions.

The United States market has remained flat over the last week but is up 20% over the past year, with earnings forecast to grow by 19% annually. In this context, growth companies with significant insider ownership can be particularly appealing as they often align management interests with those of shareholders, potentially enhancing long-term performance.

In the last week, the market has stayed flat, but it's up 20% over the past year with earnings forecast to grow by 19% annually. As investors navigate these conditions, identifying stocks with strong fundamentals becomes crucial for capturing potential growth. Penny stocks, though a somewhat outdated term, still highlight smaller or less-established companies that can offer significant value; we've identified three such stocks that combine sound balance sheets with promising potential.

In the last week, the United States market has stayed flat, but it is up 20% over the past year with earnings forecast to grow by 19% annually. In this environment, identifying stocks with strong growth potential and solid fundamentals can uncover lesser-known opportunities that may offer significant value.